Sommaire

• • ·Editorial Board

    Page :4A

    
• • ·Evidence suggesting coronary vasodilation as the principal mechanism in the warm-up phenomenon

    Page :5A

    Kari Ylitalo, Matti Niemelä, Markku Linnaluoto, Juhani Valkama, Kimmo Mattila, Keijo Peuhkurinen

    Résumé Résumé Plan Plan  
• • ·PRINCE’s prospects: Statins, inflammation, and coronary risk

    Page :881-883

    Rabih R. Azar, David D. Waters

    Plan Plan
• • ·Which ?-blocker for heart failure?

    Page :884-888

    Kirkwood F. Adams

    Plan Plan
• • ·Aortic counterpulsation in acute myocardial infarction: Physiologically important but does the patient benefit?

    Page :889-892

    E.Magnus Ohman, Judith S. Hochman

    
• • ·The Pravastatin Inflammation CRP Evaluation (PRINCE): Rationale and design

    Page :893-898

    Michelle A. Albert, Joan Staggers, Paul Chew, Paul M. Ridker, on behalf of the PRINCE Investigators

    Résumé Résumé Plan Plan  
• • ·Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: Results of a meta-analysis

    Page :899-907

    Milton Packer, George V. Antonopoulos, Jesse A. Berlin, Jesse Chittams, Marvin A. Konstam, James E. Udelson

    Résumé Résumé Plan Plan  
• • ·Hemodynamics as surrogate end points for survival in advanced heart failure: An analysis from FIRST

    Page :908-914

    Monica R. Shah, Sandra S. Stinnett, Steven E. McNulty, Mihai Gheorghiade, Faiez Zannad, Barry Uretsky, Kirkwood F. Adams, Robert M. Califf, Christopher M. O’Connor

    Résumé Résumé Plan Plan  
• • ·Prediction of the extent and severity of left ventricular dysfunction in anterior acute myocardial infarction by the admission electrocardiogram

    Page :915-924

    Yochai Birnbaum, Douglas A. Criger, Galen S. Wagner, Boris Strasberg, Aviv Mager, Kathy Gates, Christopher B. Granger, Allan M. Ross, Gabriel I. Barbash

    Résumé Résumé Plan Plan  
• • ·Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during ?-blocker therapy: A potential of hormone-guided treatment

    Page :925-932

    Keisuke Kawai, Katsuya Hata, Hideyuki Takaoka, Hiroya Kawai, Mitsuhiro Yokoyama

    Résumé Résumé Plan Plan  
• • ·The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2

    Page :933-939

    Hal V. Barron, Nathan R. Every, Lori S. Parsons, Brad Angeja, Robert J. Goldberg, Joel M. Gore, Tony M. Chou, for the Investigators in the National Registry of Myocardial Infarction 2

    Résumé Résumé Plan Plan  
• • ·Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty

    Page :940-943

    Toru Kato, Tetsuo Kamiyama, Yoshiaki Maruyama, Shugo Tanaka, Nobuo Yoshimoto

    Résumé Résumé Plan Plan  
• • ·Does the presence of hibernating myocardium in patients with impaired left ventricular contraction affect QT dispersion?

    Page :944-948

    Abdallah Al Mohammad, Ian R. Mahy, Aidan Buckley, Robert I. Cargill, Murdoch Y. Norton, Andrew E. Welch, Stephen Walton

    Résumé Résumé Plan Plan  
• • ·Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women’s Atorvastatin Trial on Cholesterol (WATCH)

    Page :949-956

    Ruth McPherson, Carmella Angus, Peter Murray, Jacques Genest, for the WATCH Investigators

    Résumé Résumé Plan Plan  
• • ·Randomized clinical trials and recent patterns in the use of statins

    Page :957-963

    Thomas J. Wang, Randall S. Stafford, John C. Ausiello, Christine E. Chaisson

    Résumé Résumé Plan Plan  
• • ·Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry

    Page :964-970

    John G. Webb, Timothy A. Sanborn, Lynn A. Sleeper, Ronald G. Carere, Christopher E. Buller, James N. Slater, Kenneth W. Baran, Patrick T. Koller, J.David Talley, Mark Porway, Judith S. Hochman, for the SHOCK Investigators

    Résumé Résumé Plan Plan  
• • ·A Randomised Trial of Endoluminal Reconstruction Comparing the NIR Stent and the Wallstent in Angioplasty of Long Segment Coronary Disease: Results of the RENEWAL Study

    Page :971-976

    Thuraia Nageh, Adam J. de Belder, Martyn R. Thomas, Ian L. Williams, Ray J. Wainwright

    Résumé Résumé Plan Plan
• • ·Ten-year mortality rate in relation to observations at a bicycle exercise test in patients with a suspected or confirmed ischemic event but no or only minor myocardial damage: Influence of subsequent revascularization

    Page :977-984

    Björn W. Karlson, Margareta Sjölin, Jonny Lindqvist, Kenneth Caidahl, Johan Herlitz

    Résumé Résumé Plan Plan  
• • ·Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinase-MB, myoglobin, and troponin I

    Page :985-991

    David Bar-Or, James V. Winkler, Karyl VanBenthuysen, Lisbeth Harris, Edward Lau, Fred W. Hetzel

    Résumé Résumé Plan Plan
• • ·Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study

    Page :992-998

    Arzu Ilercil, Richard B. Devereux, Mary J. Roman, Mary Paranicas, Michael J. O’Grady, Thomas K. Welty, David C. Robbins, Richard R. Fabsitz, Barbara V. Howard, Elisa T. Lee

    Résumé Résumé Plan Plan
• • ·Long-term prognostic value of ²⁰¹Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting

    Page :999-1006

    Yves Cottin, Kathy Rezaizadeh, Claude Touzery, Isabelle Barillot, Marianne Zeller, Sylviane Prevot, Isabelle L’Huillier, Olivier Ressencourt, Francis André, Michel Fraison, Pierre Louis, François Brunotte, Jean Eric Wolf

    Résumé Résumé Plan Plan  
• • ·Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging—A pilot study

    Page :1007-1013

    Ralf Wassmuth, Suzanne Lentzsch, Uta Erdbruegger, Jeanette Schulz-Menger, Bernd Doerken, Rainer Dietz, Matthias G. Friedrich

    Résumé Résumé Plan Plan  
• • ·Reproducibility of exaggerated blood pressure response to exercise in healthy patients

    Page :1014-1017

    Y. Sharabi, Z. Almer, A. Hanin, F.H. Messerli, R. Ben-Cnaan, E. Grossman

    Résumé Résumé Plan Plan  
• • ·Potential impact of socioeconomic differences on clinical outcomes in international clinical trials

    Page :1019-1024

    Marcelo C. Shibata, Marcus D. Flather, Diego Perez de Arenaza, Duolao Wang, J.Conor O’Shea

    Plan Plan  
• • ·Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: Fundamental principles and the contribution of platelets and thrombin

    Page :1025-1037

    Richard C. Becker, Paul Eisenberg, Alexander G.G. Turpie

    Plan Plan  
• • ·Better delivery of standard antithrombotic care

    Page :1038-1042

    Henry Bussey

    Plan Plan
• • ·Novel intravenous antithrombins

    Page :1043-1047

    Jerrold H. Levy

    Plan Plan